Omega-3 may reduce risk of irregular heart beat: Harvard study

By Stephen Daniells

- Last updated on GMT

Omega-3 may reduce risk of irregular heart beat: Harvard study
Increased levels of omega-3 fatty acids may reduce the risk of atrial fibrillation, the most common irregular heart beat (chronic arrhythmia) in adults, by about 30%, says a new study.

Results published in Circulation​ indicated that the highest average levels of omega-3 fatty acids were associated with a 29% reduction in the risk of atrial fibrillation, compared with the lowest average levels, while the effects seemingly linked to DHA levels more so that EPA.

“Our findings suggest that omage-3 fatty acids could be beneficial for the prevention of onset of atrial fibrillation in older individuals, a group at particularly high risk,”​ wrote researchers led by Dariush Mozaffarian, MD, DrPH, from the Harvard School of Public Health.

“Given the aging of the population, the significant and growing public health burden of atrial fibrillation, and the limited treatment options once atrial fibrillation develops, our results highlight the need to investigate atrial physiological and arrhythmic mechanisms affected by total and individual [omega-3 fatty acids] and to test the efficacy of [omega-3 fatty acids] for preventing new onset of atrial fibrillation among older adults in a randomized intervention.”

Welcome

The study’s findings were described as ‘very promising’​ by Harry Rice, PhD, VP, regulatory & scientific affairs for the Global Organization for EPA and DHA Omega-3s (GOED).

Dr Rice told NutraIngredients-USA: “Whenever there is the prospect of a substance having a role in the primary prevention of a disease, it's a potential game changer from an economic, not to mention quality of life, perspective.

“I look forward to learning what follow-up studies may be in the works. This is very promising!”

Heart health

The study adds to an ever-growing body of science supporting the potential cardiovascular and brain health benefits of omega-3 fatty acids.

The heart health benefits of fish oil, and the omega-3 fatty acids it contains, are well-documented, being first reported in the early 1970s by Dr Jorn Dyerberg and his co-workers in The Lancet​ and The American Journal of Clinical Nutrition​.

To date, the polyunsaturated fatty acids (PUFAs) have been linked to improvements in blood lipid levels, a reduced tendency of thrombosis, blood pressure and heart rate improvements, and improved vascular function.

Study details

The new study is said to be the first prospective study to investigate the association of fatty acid biomarkers with atrial fibrillation among older Americans.

Dr Mozaffarian and his co-workers analyzed data from 3,326 US men and women with an average age of 74. During the course of the study, 789 cases of atrial fibrillation were reported.

Results showed that the highest average levels of both total omega-3 fatty acids and DHA (docosahexaenoic acid) were associated with a reduction in the risk of atrial fibrillation of about 25%.

“When evaluated continuously as percent of total fatty acids, each 1% higher total [omega-3 fatty acids] was associated with 9% lower risk of atrial fibrillation,”​ added the researchers.

However, levels of EPA (eicosapentaenoic acid) and DPA (docosapentaenoic acid) were not associated with atrial fibrillation risk.

Supporting the guidelines

“Several national and international dietary guidelines recommend 1 to 2 servings of fish per week (preferably oily fish) to obtain about 250 mg or more [omega-3 fatty acids] per day, based on the consistency of evidence supporting the efficacy of [omega-3 fatty acids] to reduce the risk of coronary heart disease mortality,”​ wrote Dr Mozaffarian and his co-workers.

“Our findings provide evidence that dietary [omega-3 fatty acids] could also provide protection against onset of atrial fibrillation later in life.

“The observed attenuation of the inverse association between fish consumption and incidence of atrial fibrillation after adjustment for phospholipid [omega-3 fatty acids] levels further supports the hypothesis that [omega-3 fatty acids] are a major bioactive component in fatty fish that could lower risk of atrial fibrillation.”

Source: Circulation
Volume 125, Pages 1084-1093, doi:10.1161/CIRCULATIONAHA.111.062653
“Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids With Incident Atrial Fibrillation in Older Adults: The Cardiovascular Health Study”
Authors: J.H.Y. Wu, R.N. Lemaitre, I.B. King, X. Song, F.M. Sacks, E.B. Rimm, S.R. Heckbert, D.S. Siscovick, D. Mozaffarian

Related news

Show more

Related products

show more

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals Quality Partnership Program

Gemini Pharmaceuticals | 09-Oct-2017 | Technical / White Paper

A Brand Owner/Own Label Distributor is 100% responsible for the quality of their products - not the Contract Manufacturing Organization. This is exactly...

Resveratrol – Revitalizing Cognitive Function

Resveratrol – Revitalizing Cognitive Function

Evolva | 29-Sep-2017 | Technical / White Paper

Cognitive decline is fast becoming the biggest concern of the 65+ population. A population which is set to reach 1.1 billion by 2030*.  · 80% of 60+ take...

Product Cost Reduction Strategies for the Brand Owner

Product Cost Reduction Strategies for the Brand Owner

Gemini Pharmaceuticals | 11-Sep-2017 | Technical / White Paper

Brand Owners are feeling product price pressure from all corners these days. Consumers are demanding more of the products they buy and want them at a lower...

NattoPharma

12 Reasons MenaQ7® is the Superior Vitamin K2

NattoPharma USA, Inc. | 11-Sep-2017 | Data Sheet

Vitamin K2 as MK-7 supplements are truly changing the face of global health, benefiting old and young alike. We know this because NattoPharma has single-handedly...

Related suppliers

2 comments

MAGNESIUM Also...

Posted by Nature Girl,

Magnesium (at least 500mg) will stop the arryhthmia and attrial fibrillation as well. It can also stop SUDDEN DEATH.

Report abuse

Great, but it is missing something that can help people.

Posted by Michael Mooney,

I started taking 3,000 mg of net EPA/DHA about seven or eight years ago when studies started showing this. It's not new news. However, once more it seems that scientists err on being too conservative. Rather than the 29% reduction they said, I have 100% reduction if I take 4,000 mg of net EPA and DHA. I used to have 10 or 15 serious events a year. 3,000 mg almost stopped my afib. 4,000 completely stops them. As is true with all nutrition, find the optimal dose, which is usually much higher than conservative doctors or scientists tell you. And of course, one can assume that my cardiovascular system benefits tremendously taking this dose. I find that 6,000 mg is too much. At that dose I bruise easily, a symptom of "too much" omega-3's.

Report abuse